Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) traded down 2.9% during trading on Tuesday . The stock traded as low as $2.98 and last traded at $3.01, with a volume of 146,483 shares. The stock had previously closed at $3.10.

KTOV has been the subject of a number of research reports. Zacks Investment Research raised shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 target price for the company in a report on Wednesday. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a report on Monday.

The stock has a 50 day moving average price of $3.96 and a 200-day moving average price of $3.97. The firm’s market capitalization is $11.83 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.